[Source: UA News] – An enzyme that normally establishes a sense of direction in developing brain cells might be a poorly understood cause of glioblastoma, the most common and devastating type of brain cancer.
The National Institutes of Health awarded $1.6 million to the University of Arizona to investigate ways to get the deranged signaling mechanism back on track and test whether the protein could serve as a candidate target for new cancer-fighting drugs.
For more information: UA Receives $1.6M to Study New Ways to Fight Brain Cancer